Affiliations
AffiliationsItem in Clipboard
Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer eliminationNuhu Tumba et al. J Contemp Brachytherapy. 2022 Jun.
. 2022 Jun;14(3):241-247. doi: 10.5114/jcb.2022.116414. Epub 2022 May 26. AffiliationsItem in Clipboard
AbstractPurpose: Sub-Saharan Africa has the highest burden of cervical cancer in the world. The African continent has only 5% of the world's cancer care resources, and brachytherapy is an important part of treatment of cervical cancer. This study explored the availability of brachytherapy units in Africa.
Material and methods: We used publicly available data on cervical cancer and brachytherapy from GLOBOCAN 2018 database hosted by IARC and Directory of Radiotherapy Centers (DIRAC) presented by IAEA, respectively. Number of brachytherapy units per 1,000 new cases was calculated as an index for comparison between groups.
Results: There are 101 brachytherapy units in 20 African countries, accounting for 3% (101/3,375) of total global units. Sub-Saharan Africa accounts for half of these units (50/101). Egypt has the highest number of units per 1,000 new cases (23.7 units/1,000 new cases), while Nigeria has the least with 0.13 units per 1,000 new cases. No country in central African region has a brachytherapy unit. More than 70% of brachytherapy units are located in five countries (Algeria, Kenya, Egypt, Morocco, and South Africa).
Conclusions: In order to treat 90 percent of invasive cervical cancer on the continent, Africa needs a continental political action plan and massive investment in brachytherapy equipment over the next ten years.
Keywords: brachytherapy; cervical cancer; elimination; sub-Saharan Africa.
Copyright © 2022 Termedia.
Conflict of interest statementThe authors report no conflict of interest.
FiguresFig. 1
Brachytherapy availability in Africa. Varying…
Fig. 1
Brachytherapy availability in Africa. Varying shades of green show the availability and density…
Fig. 1Brachytherapy availability in Africa. Varying shades of green show the availability and density of brachytherapy units in countries where they are available. Blue color shows where there are no brachytherapy units
Fig. 2
Regional distribution of brachytherapy units…
Fig. 2
Regional distribution of brachytherapy units in Africa
Fig. 2Regional distribution of brachytherapy units in Africa
Similar articlesFiagbedzi E, Atuwo-Ampoh VD, Ofori IN, Nyarko S, Adomako A, Hasford F, Amlalo JG, Gorleku PN. Fiagbedzi E, et al. Clin Transl Radiat Oncol. 2024 Oct 28;50:100880. doi: 10.1016/j.ctro.2024.100880. eCollection 2025 Jan. Clin Transl Radiat Oncol. 2024. PMID: 39553385 Free PMC article. Review.
Elbanna M, Pynda Y, Kalinchuk O, Rosa A, Abdel-Wahab M. Elbanna M, et al. Lancet Oncol. 2023 Sep;24(9):e376-e384. doi: 10.1016/S1470-2045(23)00299-1. Lancet Oncol. 2023. PMID: 37657478 Review.
Bray F, Parkin DM; African Cancer Registry Network. Bray F, et al. Lancet Oncol. 2022 Jun;23(6):719-728. doi: 10.1016/S1470-2045(22)00270-4. Epub 2022 May 9. Lancet Oncol. 2022. PMID: 35550275 Review.
Post LA, Argaw ST, Jones C, Moss CB, Resnick D, Singh LN, Murphy RL, Achenbach CJ, White J, Issa TZ, Boctor MJ, Oehmke JF. Post LA, et al. J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248. J Med Internet Res. 2020. PMID: 33211026 Free PMC article.
Elmore SNC, Polo A, Bourque JM, Pynda Y, van der Merwe D, Grover S, Hopkins K, Zubizarreta E, Abdel-Wahab M. Elmore SNC, et al. Lancet Oncol. 2021 Sep;22(9):e391-e399. doi: 10.1016/S1470-2045(21)00351-X. Lancet Oncol. 2021. PMID: 34478675 Free PMC article.
Fiagbedzi E, Atuwo-Ampoh VD, Ofori IN, Nyarko S, Adomako A, Hasford F, Amlalo JG, Gorleku PN. Fiagbedzi E, et al. Clin Transl Radiat Oncol. 2024 Oct 28;50:100880. doi: 10.1016/j.ctro.2024.100880. eCollection 2025 Jan. Clin Transl Radiat Oncol. 2024. PMID: 39553385 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3